BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1242 related articles for article (PubMed ID: 3381827)

  • 1. The evaluation of the data collection process for a multicenter, population-based, case-control design.
    Wingo PA; Ory HW; Layde PM; Lee NC
    Am J Epidemiol; 1988 Jul; 128(1):206-17. PubMed ID: 3381827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarette smoking and the risk of epithelial ovarian cancer.
    Franks AL; Lee NC; Kendrick JS; Rubin GL; Layde PM
    Am J Epidemiol; 1987 Jul; 126(1):112-7. PubMed ID: 3591776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives and breast, endometrial, and ovarian cancers. The Cancer and Steroid Hormone Study Group, Atlanta Georgia.
    Gwinn ML
    J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S83-7. PubMed ID: 12268773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptives and breast cancer risk among younger women.
    Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN
    J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.
    Wu ML; Whittemore AS; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J
    Am J Epidemiol; 1988 Dec; 128(6):1216-27. PubMed ID: 3195563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and gynecologic cancer: an update for the 1990s.
    Kaunitz AM
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1171-6. PubMed ID: 1415442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agreement between oral contraceptive users and prescribers: implications for case-control studies.
    van Leeuwen FE; van Duijn CM; Camps MH; Kempers BA; Mentjens MF; Mulder HB; Schouten EG; Zwijsen RM; Rookus MA
    Contraception; 1992 May; 45(5):399-408. PubMed ID: 1623713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women.
    Hunter DJ; Manson JE; Colditz GA; Chasan-Taber L; Troy L; Stampfer MJ; Speizer FE; Willett WC
    Contraception; 1997 Dec; 56(6):373-8. PubMed ID: 9494771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Events of reproductive life and the incidence of epithelial ovarian cancer.
    Risch HA; Weiss NS; Lyon JL; Daling JR; Liff JM
    Am J Epidemiol; 1983 Feb; 117(2):128-39. PubMed ID: 6681935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of oral contraceptive relationships on breast cancer risk by selected factors among younger women.
    Brinton LA; Gammon MD; Malone KE; Schoenberg JB; Daling JR; Coates RJ
    Contraception; 1997 Apr; 55(4):197-203. PubMed ID: 9179450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives as related to cancer and benign lesions of the breast.
    Fasal E; Paffenbarger RS
    J Natl Cancer Inst; 1975 Oct; 55(4):767-73. PubMed ID: 1185801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer of the breast and reproductive tract in relation to use of oral contraceptives.
    Schlesselman JJ
    Contraception; 1989 Jul; 40(1):1-38. PubMed ID: 2673658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB; Porterfield D
    Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives and breast cancer.
    Brinton LA; Hoover R; Szklo M; Fraumeni JF
    Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer before age 45 and oral contraceptive use: new findings.
    Miller DR; Rosenberg L; Kaufman DW; Stolley P; Warshauer ME; Shapiro S
    Am J Epidemiol; 1989 Feb; 129(2):269-80. PubMed ID: 2912040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral contraceptive use and the risk of cancer].
    Wingo PA
    Fertil Contracept Sex; 1989 Feb; 17(2):125-32. PubMed ID: 12281877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of recalled and validated oral contraceptive histories.
    Nischan P; Ebeling K; Thomas DB; Hirsch U
    Am J Epidemiol; 1993 Nov; 138(9):697-703. PubMed ID: 8237985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case-control study of cancer of the endometrium.
    Kelsey JL; LiVolsi VA; Holford TR; Fischer DB; Mostow ED; Schwartz PE; O'Connor T; White C
    Am J Epidemiol; 1982 Aug; 116(2):333-42. PubMed ID: 7114042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign breast tumor and estrogenic hormones: a population-based retrospective study.
    Nomura A; Comstock GW
    Am J Epidemiol; 1976 May; 103(5):439-44. PubMed ID: 179318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.